VAERS reports by lot

Moderna COVID-19 lot AR9237B: VAERS reports

167 VAERS reports list lot AR9237B as a Moderna COVID-19 vaccine, received between 2022-06-29 and 2023-08-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
167
Reports
4%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5524%
Gastrointestinal3817%
Respiratory2611%
Dermatological (non-injection-site)2410%
Injection-site / Local reaction2310%
Neurological198%
Psychiatric / Neuropsychiatric136%
Cardiac / Cardiovascular115%
Allergic / Anaphylactic104%
Thrombotic / Hematological52%
Musculoskeletal31%
Autoimmune / Immune-mediated21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California70
Missouri14
Pennsylvania11
Texas8
Minnesota7
Alaska6
Wisconsin5
Oregon5
Nevada4
Florida4
Nebraska3
Alabama2

Reports by month received

2022-061
2022-0727
2022-0853
2022-0930
2022-105
2022-116
2022-1216
2023-0110
2023-027
2023-033
2023-047
2023-061
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.